PANACEABIO.NS

Panacea Biotec Limited

HealthcareBiotechnologyININRPeers →Country macro →

$536.40

+0.26%Jun 19, 2026

AI Brief

Market cap

$32.94B

52w range

—

P / E

—

EPS · FY 2026

$-0.88

Volume

—

Revenue · FY 2026

$6.4B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Panacea Biotec Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$536.40

Change

+29.24%

Period high

$607.75

Period low

$296.05

Period start

$415.052025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

PANACEABIO.NS

536.40+29.24%

H 647.00L 292.40MA50 419.80MA200 390.22Avg vol 549K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Technology
+2.51%
Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Consumer Defensive
-0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Real Estate
-0.99%
Healthcare
-1.51%

Top industries (issuer's industry highlighted)

Biotechnology
+0.28%
Oil & Gas Energy
+8.53%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Electronic Gaming & Multimedia
+5.23%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Grocery Stores
-4.35%
Financial - Mortgages
+4.08%
Broadcasting
+4.00%
Computer Hardware
-3.67%
Internet Content & Information
+3.58%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for PANACEABIO.NS.

Peers

No peer list available for PANACEABIO.NS.

Total assets

$12.62B

Total debt

$236.6M

Cash & equiv

$643.7M

Operating CF

$173.4M

Free cash flow

-$367.5M

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$6.4B	-$377.2M	-$53.7M	$-0.88	-0.84%